Indian drug major Dr Reddy's Laboratories Limited has reached a settlement with the US government agencies for $ 5 million in a six-year-old case regarding the complaints of a potential harm from the package of blister-packed prescription products to children.
In June last year, the US Consumer Product Safety Commission (CPSC) had requested the US Department of Justice to impose a civil penalty on Dr Reddy's for alleged violations of provisions related to the child-resistant packaging in at least five prescription drugs.
While disagreeing with these accusations, the company on Tuesday said that it has chosen to settle

)